Northwestern Mutual Investment Management Company’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.67M | Sell |
18,460
-108
| -0.6% | -$9.05K | 0.02% | 422 |
|
|
2026
Q1 | $1.49M | Buy |
18,568
+26
| +0.1% | +$2.14K | 0.02% | 419 |
|
|
2025
Q4 | $1.58M | Sell |
18,542
-169
| -0.9% | -$13.9K | 0.02% | 385 |
|
|
2025
Q3 | $1.46M | Sell |
18,711
-2
| -0% | -$156 | 0.02% | 418 |
|
|
2025
Q2 | $1.46M | Sell |
18,713
-46
| -0.2% | -$3.43K | 0.02% | 398 |
|
|
2025
Q1 | $1.36M | Buy |
18,759
+32
| +0.2% | +$2.29K | 0.02% | 414 |
|
|
2024
Q4 | $1.39M | Sell |
18,727
-366
| -2% | -$25.6K | 0.03% | 412 |
|
|
2024
Q3 | $1.26M | Sell |
19,093
-83
| -0.4% | -$6.03K | 0.03% | 458 |
|
|
2024
Q2 | $1.77M | Sell |
19,176
-69
| -0.4% | -$6.11K | 0.05% | 275 |
|
|
2024
Q1 | $1.84M | Buy |
19,245
+47
| +0.2% | +$3.95K | 0.05% | 270 |
|
|
2023
Q4 | $1.46M | Buy |
19,198
+10
| +0.1% | +$696 | 0.04% | 341 |
|
|
2023
Q3 | $1.33M | Buy |
19,188
+65
| +0.3% | +$5.22K | 0.04% | 326 |
|
|
2023
Q2 | $1.8M | Sell |
19,123
-311
| -2% | -$27K | 0.05% | 203 |
|
|
2023
Q1 | $1.61M | Buy |
19,434
+56
| +0.3% | +$4.4K | 0.04% | 219 |
|
|
2022
Q4 | $1.45M | Sell |
19,378
-3,647
| -16% | -$281K | 0.04% | 163 |
|
|
2022
Q3 | $1.9M | Sell |
23,025
-4,568
| -17% | -$440K | 0.05% | 136 |
|
|
2022
Q2 | $2.62M | Sell |
27,593
-42
| -0.2% | -$4.35K | 0.06% | 128 |
|
|
2022
Q1 | $3.25M | Sell |
27,635
-3,283
| -11% | -$368K | 0.07% | 122 |
|
|
2021
Q4 | $4M | Sell |
30,918
-314
| -1% | -$36.6K | 0.08% | 122 |
|
|
2021
Q3 | $3.54M | Buy |
31,232
+3,002
| +11% | +$343K | 0.07% | 123 |
|
|
2021
Q2 | $2.92M | Sell |
28,230
-82
| -0.3% | -$7.73K | 0.05% | 140 |
|
|
2021
Q1 | $2.37M | Sell |
28,312
-5,890
| -17% | -$498K | 0.04% | 161 |
|
|
2020
Q4 | $3.12M | Buy |
34,202
+162
| +0.5% | +$13.4K | 0.04% | 182 |
|
|
2020
Q3 | $2.35M | Hold |
34,040
| – | – | 0.03% | 211 |
|
|
2020
Q2 | $2.35M | Buy |
34,040
+1,418
| +4% | +$101K | 0.03% | 209 |
|
|
2020
Q1 | $2.05M | Buy |
32,622
+8,316
| +34% | +$600K | 0.03% | 198 |
|
|
2019
Q4 | $1.89M | Buy |
24,306
+546
| +2% | +$42.6K | 0.03% | 244 |
|
|
2019
Q3 | $1.74M | Buy |
23,760
+36
| +0.2% | +$2.53K | 0.04% | 250 |
|
|
2019
Q2 | $1.46M | Sell |
23,724
-70,989
| -75% | -$4.29M | 0.03% | 296 |
|
|
2019
Q1 | $6.04M | Buy |
94,713
+159
| +0.2% | +$9.07K | 0.11% | 166 |
|
|
2018
Q4 | $4.83M | Sell |
94,554
-15,372
| -14% | -$778K | 0.08% | 184 |
|
|
2018
Q3 | $6.38M | Sell |
109,926
-11,163
| -9% | -$546K | 0.1% | 182 |
|
|
2018
Q2 | $5.88M | Buy |
121,089
+6,402
| +6% | +$299K | 0.09% | 207 |
|
|
2018
Q1 | $5.33M | Sell |
114,687
-28,710
| -20% | -$1.25M | 0.09% | 203 |
|
|
2017
Q4 | $5.39M | Buy |
143,397
+1,374
| +1% | +$50.4K | 0.09% | 228 |
|
|
2017
Q3 | $5.17M | Sell |
142,023
-2,409
| -2% | -$91.9K | 0.08% | 229 |
|
|
2017
Q2 | $5.69M | Buy |
144,432
+15,570
| +12% | +$568K | 0.1% | 205 |
|
|
2017
Q1 | $4.04M | Buy |
128,862
+94,347
| +273% | +$2.95M | 0.07% | 245 |
|
|
2016
Q4 | $1.08M | Sell |
34,515
-28,668
| -45% | -$929K | 0.02% | 463 |
|
|
2016
Q3 | $2.54M | Buy |
63,183
+38,943
| +161% | +$1.47M | 0.05% | 199 |
|
|
2016
Q2 | $806K | Sell |
24,240
-324
| -1% | -$11.1K | 0.02% | 370 |
|
|
2016
Q1 | $722K | Sell |
24,564
-76,203
| -76% | -$2.1M | 0.02% | 410 |
|
|
2015
Q4 | $2.65M | Buy |
100,767
+879
| +0.9% | +$22.8K | 0.06% | 183 |
|
|
2015
Q3 | $2.37M | Sell |
99,888
-6
| -0% | -$145 | 0.05% | 201 |
|
|
2015
Q2 | $2.37M | Buy |
99,894
+6,270
| +7% | +$141K | 0.05% | 221 |
|
|
2015
Q1 | $2.22M | Buy |
+93,624
| New | +$2.1M | 0.05% | 240 |
|
Other funds holding EW
WT
Northwestern Mutual Investment Management Company's EW Position: Q2 2026 in Review
Northwestern Mutual Investment Management Company reduced its Edwards Lifesciences (EW) stake by 0.58% in Q2 2026, selling an estimated $9.05K and leaving 18,460 shares worth $1.67M. The position accounts for 0.02% of the portfolio, ranked #422.
Northwestern Mutual Investment Management Company first reported a position in EW in Q1 2015 and has held it in 46 quarters since. The position peaked at $6.38M in Q3 2018. 979 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Northwestern Mutual Investment Management Company held 18,460 shares of Edwards Lifesciences worth $1.67M as of Q2 2026.
- Northwestern Mutual Investment Management Company sold 108 Edwards Lifesciences shares in Q2 2026, an estimated $9.05K.
- Edwards Lifesciences made up 0.02% of Northwestern Mutual Investment Management Company's portfolio in Q2 2026, its #422 holding.
- Northwestern Mutual Investment Management Company first reported a position in Edwards Lifesciences in Q1 2015 and has held it in 46 quarters since.
- Northwestern Mutual Investment Management Company's Edwards Lifesciences position peaked at $6.38M in Q3 2018.
- 979 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Northwestern Mutual Investment Management Company's 13F filing for Q2 2026, filed 12 Aug 2026.